• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克因子 5 与免疫浸润相关,可作为肺腺癌的预后生物标志物。

Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Zhejiang University, Qingchun Road 79, Hangzhou, China, 310009.

Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou, China, 310009.

出版信息

Int J Med Sci. 2021 Jan 1;18(2):448-458. doi: 10.7150/ijms.51297. eCollection 2021.

DOI:10.7150/ijms.51297
PMID:33390814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757139/
Abstract

Lung adenocarcinoma (LUAD) is the predominant subtype of lung cancer with a relatively poor prognosis. The dramatic improvements of new immunotherapy strategies have shown promising results in lung cancer patients. This study aimed to elucidate the functions of immune-associated genes in LUAD prognosis and pathogenesis by analyzing public databases. We obtained expression profiles of LUAD patients from The Cancer Genome Atlas (TCGA) database and applied the ESTIMATE algorithm to calculate immune scores and stromal scores. A series of microenvironment-related genes with prognostic value was then identified. Of note, heat shock factor 5 (HSF5) was found to be decreased in LUAD patients and positively correlated with overall survival, which was further confirmed in the Gene Expression Omnibus (GEO) database. Moreover, Gene Ontology (GO) analysis based on the correlated genes of HSF5 demonstrated that HSF5 expression was significantly associated with the immune response and inflammatory activities. Based on the Tumor IMmune Estimation Resource (TIMER) and Gene Expression Profiling Interactive Analysis (GEPIA) datasets, HSF5 expression showed strong correlations with various immune cell infiltration and diverse immune marker sets. These findings suggest that HSF5 can be used as a promising biomarker for determining prognosis and immune infiltration in LUAD patients.

摘要

肺腺癌 (LUAD) 是肺癌的主要亚型,预后相对较差。新的免疫治疗策略的显著改善已经在肺癌患者中显示出了有前景的结果。本研究旨在通过分析公共数据库来阐明免疫相关基因在 LUAD 预后和发病机制中的作用。我们从癌症基因组图谱 (TCGA) 数据库中获取 LUAD 患者的表达谱,并应用 ESTIMATE 算法计算免疫评分和基质评分。然后确定了一系列具有预后价值的微环境相关基因。值得注意的是,发现热休克因子 5 (HSF5) 在 LUAD 患者中降低,并与总生存期呈正相关,这在基因表达综合数据库 (GEO) 中也得到了进一步证实。此外,基于 HSF5 相关基因的基因本体 (GO) 分析表明,HSF5 的表达与免疫反应和炎症活性显著相关。基于肿瘤免疫估计资源 (TIMER) 和基因表达谱交互式分析 (GEPIA) 数据集,HSF5 表达与各种免疫细胞浸润和不同的免疫标志物集显示出强烈的相关性。这些发现表明,HSF5 可以作为 LUAD 患者确定预后和免疫浸润的有前途的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/877b6534d3b3/ijmsv18p0448g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/8069e0ceb91b/ijmsv18p0448g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/4b99b2bf5f31/ijmsv18p0448g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/b9dd27ef1599/ijmsv18p0448g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/af3c6e0b759d/ijmsv18p0448g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/346f63a4299a/ijmsv18p0448g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/877b6534d3b3/ijmsv18p0448g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/8069e0ceb91b/ijmsv18p0448g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/4b99b2bf5f31/ijmsv18p0448g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/b9dd27ef1599/ijmsv18p0448g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/af3c6e0b759d/ijmsv18p0448g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/346f63a4299a/ijmsv18p0448g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b8/7757139/877b6534d3b3/ijmsv18p0448g008.jpg

相似文献

1
Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.热休克因子 5 与免疫浸润相关,可作为肺腺癌的预后生物标志物。
Int J Med Sci. 2021 Jan 1;18(2):448-458. doi: 10.7150/ijms.51297. eCollection 2021.
2
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
3
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.新型基质/免疫评分相关 P2RY12 在肺腺癌微环境中的预后价值及免疫浸润分析。
Int Immunopharmacol. 2021 Sep;98:107734. doi: 10.1016/j.intimp.2021.107734. Epub 2021 Jun 25.
4
DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration.DHX37 通过免疫浸润影响肝细胞癌和肺腺癌的预后。
J Immunol Res. 2020 Dec 30;2020:8835393. doi: 10.1155/2020/8835393. eCollection 2020.
5
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.NPM1 是肺腺癌免疫浸润的预后生物标志物,与 m6A 修饰和糖酵解有关。
Front Immunol. 2021 Jul 16;12:724741. doi: 10.3389/fimmu.2021.724741. eCollection 2021.
6
Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.肿瘤突变负荷与免疫浸润联合用于肺腺癌的预后评估。
Int Immunopharmacol. 2021 Sep;98:107807. doi: 10.1016/j.intimp.2021.107807. Epub 2021 Jun 25.
7
Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma.七个干扰素 γ 反应基因作为一个预后风险标志物与肺腺癌中的免疫浸润相关。
Aging (Albany NY). 2021 Apr 4;13(8):11381-11410. doi: 10.18632/aging.202831.
8
Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.肺腺癌的免疫浸润特征及其临床意义:基于基因表达的回顾性研究。
J Cell Biochem. 2020 Nov;121(11):4431-4439. doi: 10.1002/jcb.29667. Epub 2020 Jan 31.
9
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.
10
Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma.连接黏附分子样蛋白(JAML)与肺腺癌的预后和免疫浸润相关。
Med Sci Monit. 2022 Jan 16;28:e933503. doi: 10.12659/MSM.933503.

引用本文的文献

1
A guide to heat shock factors as multifunctional transcriptional regulators.热休克因子作为多功能转录调节因子的指南。
FEBS J. 2025 Aug;292(16):4133-4155. doi: 10.1111/febs.70139. Epub 2025 Jun 2.
2
The fusion gene hsf5-rnf43 in Nile tilapia: A potential regulator in the maintenance of testis function and sexual differentiation.尼罗罗非鱼中的融合基因hsf5-rnf43:维持睾丸功能和性别分化的潜在调节因子。
iScience. 2023 Oct 21;26(11):108284. doi: 10.1016/j.isci.2023.108284. eCollection 2023 Nov 17.
3
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.

本文引用的文献

1
Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data.基于 TCGA 数据的综合分析对肺腺癌组织细胞因子表达的临床病理预后意义的系统评估。
Sci Rep. 2019 Apr 19;9(1):6301. doi: 10.1038/s41598-019-42345-0.
2
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.非小细胞肺癌的免疫微环境与手术后的预后相关。
Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10.
3
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.
靶向 HSF1 治疗癌症:机制与抑制剂开发。
Theranostics. 2023 Apr 17;13(7):2281-2300. doi: 10.7150/thno.82431. eCollection 2023.
4
Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinoma.整合分析和实验探索与肺腺癌不良预后、免疫浸润和癌症进展相关的血管生成调节剂。
J Transl Med. 2021 Aug 21;19(1):361. doi: 10.1186/s12967-021-03031-w.
5
Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.Zc3h12d,一种用于肺腺癌预后标志物的新型低甲基化且与免疫相关的物质。
J Inflamm Res. 2021 Jun 15;14:2389-2401. doi: 10.2147/JIR.S304278. eCollection 2021.
6
More Than Meets the Eye: Revisiting the Roles of Heat Shock Factor 4 in Health and Diseases.不谋全局者,不足谋一域:重新审视热休克因子 4 在健康和疾病中的作用。
Biomolecules. 2021 Mar 31;11(4):523. doi: 10.3390/biom11040523.
非小细胞肺癌的免疫疗法:现状与展望
Clin Cancer Res. 2019 Aug 1;25(15):4592-4602. doi: 10.1158/1078-0432.CCR-18-1538. Epub 2019 Mar 1.
4
Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer.免疫疗法用于转移性非小细胞肺癌的一线治疗。
Clin Cancer Res. 2019 May 1;25(9):2691-2698. doi: 10.1158/1078-0432.CCR-18-3904. Epub 2019 Jan 14.
5
Heat Shock Factor 5 Is Essential for Spermatogenesis in Zebrafish.热休克因子 5 对于斑马鱼的精子发生是必需的。
Cell Rep. 2018 Dec 18;25(12):3252-3261.e4. doi: 10.1016/j.celrep.2018.11.090.
6
The lung microenvironment: an important regulator of tumour growth and metastasis.肺部微环境:肿瘤生长和转移的重要调节者。
Nat Rev Cancer. 2019 Jan;19(1):9-31. doi: 10.1038/s41568-018-0081-9.
7
Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer.免疫检查点抑制剂在非小细胞肺癌中的反应预测生物标志物。
Eur J Cancer. 2019 Jan;106:144-159. doi: 10.1016/j.ejca.2018.11.002. Epub 2018 Dec 5.
8
New advances in immunotherapy for non-small cell lung cancer.非小细胞肺癌免疫治疗的新进展
Am J Transl Res. 2018 Aug 15;10(8):2234-2245. eCollection 2018.
9
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.基于 B7-CD28 家族的特征可明显区分肺腺癌的不同预后和肿瘤免疫图谱。
Int J Cancer. 2018 Nov 15;143(10):2592-2601. doi: 10.1002/ijc.31764. Epub 2018 Sep 17.
10
Roles of heat shock factor 1 beyond the heat shock response.热休克因子 1 的作用超越了热休克反应。
Cell Mol Life Sci. 2018 Aug;75(16):2897-2916. doi: 10.1007/s00018-018-2836-6. Epub 2018 May 17.